View in EDS HTML Full Text PDF Full Text

Incidence and outcomes of FGFR inhibitor-associated retinopathy of patients treated with oral erdafitinib across the clinical trial program.

Saved in:
Bibliographic Details
Title: Incidence and outcomes of FGFR inhibitor-associated retinopathy of patients treated with oral erdafitinib across the clinical trial program.
Authors: O'Hagan A; Johnson & Johnson, Spring House, PA, 19477, United States., Siefker-Radtke A; The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States., Loriot Y; Institut Gustave Roussy, Villejuif, 94805, France., Deprince K; Johnson & Johnson, Beerse, 2340, Belgium., Crow L; Johnson & Johnson, Spring House, PA, 19477, United States., Laron M; Johnson & Johnson, Milpitas, CA, 95054, United States., Adelman R; Mayo Clinic, Jacksonville, FL, 32224, United States., Sweiti H; Johnson & Johnson, Spring House, PA, 19477, United States., Triantos S; Johnson & Johnson, Spring House, PA, 19477, United States.
Source: The oncologist [Oncologist] 2026 Jun 06; Vol. 31 (7).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42127981
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Incidence and outcomes of FGFR inhibitor-associated retinopathy of patients treated with oral erdafitinib across the clinical trial program.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22O'Hagan+A%22">O'Hagan A</searchLink>; Johnson & Johnson, Spring House, PA, 19477, United States.<br /><searchLink fieldCode="AU" term="%22Siefker-Radtke+A%22">Siefker-Radtke A</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.<br /><searchLink fieldCode="AU" term="%22Loriot+Y%22">Loriot Y</searchLink>; Institut Gustave Roussy, Villejuif, 94805, France.<br /><searchLink fieldCode="AU" term="%22Deprince+K%22">Deprince K</searchLink>; Johnson & Johnson, Beerse, 2340, Belgium.<br /><searchLink fieldCode="AU" term="%22Crow+L%22">Crow L</searchLink>; Johnson & Johnson, Spring House, PA, 19477, United States.<br /><searchLink fieldCode="AU" term="%22Laron+M%22">Laron M</searchLink>; Johnson & Johnson, Milpitas, CA, 95054, United States.<br /><searchLink fieldCode="AU" term="%22Adelman+R%22">Adelman R</searchLink>; Mayo Clinic, Jacksonville, FL, 32224, United States.<br /><searchLink fieldCode="AU" term="%22Sweiti+H%22">Sweiti H</searchLink>; Johnson & Johnson, Spring House, PA, 19477, United States.<br /><searchLink fieldCode="AU" term="%22Triantos+S%22">Triantos S</searchLink>; Johnson & Johnson, Spring House, PA, 19477, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2026 Jun 06; Vol. 31 (7).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42127981
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/oncolo/oyag174
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Incidence and outcomes of FGFR inhibitor-associated retinopathy of patients treated with oral erdafitinib across the clinical trial program.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: O'Hagan A
      – PersonEntity:
          Name:
            NameFull: Siefker-Radtke A
      – PersonEntity:
          Name:
            NameFull: Loriot Y
      – PersonEntity:
          Name:
            NameFull: Deprince K
      – PersonEntity:
          Name:
            NameFull: Crow L
      – PersonEntity:
          Name:
            NameFull: Laron M
      – PersonEntity:
          Name:
            NameFull: Adelman R
      – PersonEntity:
          Name:
            NameFull: Sweiti H
      – PersonEntity:
          Name:
            NameFull: Triantos S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 06
              Text: 2026 Jun 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1549-490X
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: The oncologist
              Type: main
ResultId 1